Skinfix Triple Lipid-Peptide Cream and CeraVe Skin Renewing Night Cream are both face moisturizers, but their product pages disclose different formula details and price points (Skinfix product page; CeraVe product page).
These are not affiliate links. We earn nothing from them. Google Analytics counts clicks so we can see which products readers want us to test.
Skinfix Triple Lipid-Peptide Cream · CeraVe Skin Renewing Night Cream at Target
| Check, captured August 12, 2026 | Skinfix Triple Lipid-Peptide Cream | CeraVe Skin Renewing Night Cream |
|---|---|---|
| Public price and size | $54 for 1.7 oz (Skinfix) | $15.49 for 1.7 fl oz at Target (Target) |
| Label architecture | Skinfix advertises a 3% triple-lipid complex, 3% peptide solution and 8% humectant blend | CeraVe lists three essential ceramides, hyaluronic acid, niacinamide and peptides; the brand describes MVE controlled-release technology |
| Fragrance and essential oils | The product page says it is free of fragrance and essential oils; the ingredient list still matters for individual tolerance | CeraVe says it is free of added fragrance |
| Formula details visible in the list | Ceramide NP, AP and EOP, cholesterol, sodium hyaluronate, squalene and several emollients | Ceramide NP, AP and EOP, cholesterol, sodium hyaluronate, niacinamide, peptides and multiple emollients |
The package-price gap is $38.51. Although both labels display 1.7, one uses ounces by weight and the other fluid ounces by volume, so this page does not treat them as the same amount or calculate a comparable unit-price gap. It is a choice between two differently disclosed formula stories and a large shelf-price difference (Skinfix; Target).
What Skinfix discloses for the extra $38.51
Skinfix gives you a named percentage structure: 3% triple-lipid complex, 3% peptide solution and 8% humectant blend. Its listed formula includes three ceramides, cholesterol, squalene, sodium hyaluronate, shea butter and several emollients (Skinfix ingredients). Those are label-level differences, not proof that the cream will deliver a particular result for every person.
The page also describes a refill system for the 1.7-oz format and lists the product as free of fragrance and essential oils (Skinfix packaging and formula). If reusable packaging or the published formula structure is important to you, those are real reasons to consider the higher price. They are not evidence of a universal performance advantage.
What CeraVe still covers
CeraVe can cover the basic role of a nighttime moisturizer with ceramides, hyaluronic acid, niacinamide and peptides. Its official page and the Target listing describe it as fragrance-free or free of added fragrance, non-comedogenic and designed for overnight hydration (CeraVe; Target).
It cannot reproduce Skinfix’s named 3%/3%/8% structure, its refill packaging, or its full ingredient list. Ingredient overlap also cannot establish equal texture, spread, finish or personal tolerance. See how to read an ingredient list before treating a shared ceramide name as a complete comparison.
The practical choice
Choose Skinfix if you specifically value its disclosed lipid, peptide and humectant architecture, want the refill format, and can spend $54 without the price changing how you use it.
Choose CeraVe if you want a much lower-cost, fragrance-free night cream with ceramides and peptides, and you do not need Skinfix’s named percentages or packaging system.
Skip Skinfix if the price would make you ration a moisturizer or feel disappointed before you open it. Skip CeraVe if you are specifically looking for Skinfix’s formula disclosure and refill design; a lower price does not make the products interchangeable.
Still want Skinfix?
Read the current Skinfix Triple Lipid-Peptide Cream label directly. The brand says ingredient lists can change, so compare the package you receive with the online list before use (Skinfix).
Evidence grade: mixed
The product facts and prices are straightforward to check, but a label comparison cannot answer which cream feels better or works better for a particular person. The evidence is therefore mixed: strong for the dated label and price snapshot, limited for any product-to-product performance conclusion.